Leaflet UNASYN 250mg / 5ml powder for oral suspension


Indicated for: bacterial infections

Substance: sultamicillin (antibacterial antibiotic)

ATC: J01CR04 (Antiinfectives for systemic use | Beta-lactam antibacterials, penicillins | Combinations of penicillins, incl. beta-lactamase inhibitors)

Sultamicillin is an antibiotic used for the treatment of bacterial infections, including respiratory tract infections, skin infections, and soft tissue infections. It is a combination of ampicillin and sulbactam, which work by inhibiting bacterial cell wall synthesis and blocking beta-lactamase enzymes.

The medication is taken orally, usually twice daily, as directed by a doctor. It is important for patients to complete the full course of treatment to prevent the development of bacterial resistance.

Patients should be aware of potential side effects, such as nausea, diarrhea, or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, diarrhea, and skin rashes. In rare cases, severe reactions such as serious allergic reactions or pseudomembranous colitis may occur. Patients should be informed of these risks before starting treatment.

UNASYN 250mg/5ml powder for oral suspension PFIZER, sultamicillin

General data about UNASYN 250mg / 5ml

  • Substance: sultamicillin
  • Date of last drug list: 01-02-2025
  • Commercial code: W65046001
  • Concentration: 250mg / 5ml
  • Pharmaceutical form: powder for oral suspension
  • Packing volume: 60ml
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: HAUPT PHARMA LATINA S.R.L. - ITALIA
  • Holder: PFIZER EUROPE MA EEIG - BELGIA
  • Number: 8274/2015/01
  • Shelf life: 2 years

Pharmaceutical forms available for sultamicillin

Concentrations available for sultamicillin

  • 250mg/5ml
  • 375mg